Immix Biopharma, Inc. — Investor Relations & Filings
Filings indexed
218
across all filing types
Latest filing
2026-05-29
Regulatory Filings
Country
US
United States of America
Listing
US
IMMX
Immix Biopharma, Inc. is a clinical-stage biopharmaceutical company focused on developing cell therapies for serious diseases. The company's primary strategy is to advance Chimeric Antigen Receptor T-cell (CAR-T) therapies by addressing their key limitation: neurotoxicity. By working to overcome this side effect, ImmixBio aims to expand the use of CAR-T treatments to a wider range of patients, medical centers, and new indications, with a lead program targeting AL Amyloidosis. The company is also developing a novel class of Tissue-Specific Therapeutics (TSTx) for applications in oncology and inflammation.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 8-K | 2026-05-29 | English | |
| 8-K | 2026-05-21 | English | |
| 424B5 | 2026-05-21 | English | |
| FWP | 2026-05-21 | English | |
| 8-K | 2026-05-21 | English | |
| 10-Q - Immix Biopharma, Inc. (0001873835) (Filer) | 2026-05-07 | English |
Browse filings by year
6 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 47894489 | 8-K | 2026-05-29 | English | ||
| 46754062 | 8-K | 2026-05-21 | English | ||
| 46754084 | 424B5 | 2026-05-21 | English | ||
| 46728248 | FWP | 2026-05-21 | English | ||
| 46726620 | 8-K | 2026-05-21 | English | ||
| 43596377 | 10-Q - Immix Biopharma, Inc. (0001873835) (Filer) | 2026-05-07 | English | ||
| 33642490 | DEF 14A - Immix Biopharma, Inc. (0001873835) (Filer) | 2026-04-06 | English | ||
| 33092916 | 8-K - Immix Biopharma, Inc. (0001873835) (Filer) | 2026-03-30 | English | ||
| 33066426 | 10-K/A - Immix Biopharma, Inc. (0001873835) (Filer) | 2026-03-27 | English | ||
| 33043171 | S-8 - Immix Biopharma, Inc. (0001873835) (Filer) | 2026-03-25 | English | ||
| 33043144 | 8-K - Immix Biopharma, Inc. (0001873835) (Filer) | 2026-03-25 | English | ||
| 33043132 | 424B5 - Immix Biopharma, Inc. (0001873835) (Filer) | 2026-03-25 | English | ||
| 33043109 | 10-K - Immix Biopharma, Inc. (0001873835) (Filer) | 2026-03-25 | English | ||
| 33002269 | SCHEDULE 13G - Immix Biopharma, Inc. (0001873835) (Subject) | 2026-03-20 | English | ||
| 32145665 | SCHEDULE 13G Filing | 2026-02-17 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Adaptimmune Therapeutics PLC
Commercial-stage biopharma developing TCR T-cell therapies …
|
ADAP | GB | Manufacturing |
|
Adaptogenics Health Corp.
Formulates and distributes functional mushroom and adaptoge…
|
ADPT | CA | Manufacturing |
|
Adastra Holdings
Manufacturer and supplier of ethnobotanical and processed c…
|
XTRX | CA | Manufacturing |
|
ADBIOTECH Co.,Ltd.
Develops IgY-based immune antibodies as alternatives to vac…
|
179530 | KR | Manufacturing |
|
ADC Therapeutics SA
Commercial-stage biotech developing antibody-drug conjugate…
|
ADCT | US | Manufacturing |
|
Addex Therapeutics Ltd.
Clinical-stage biopharma developing allosteric modulators f…
|
ADXN | CH | Manufacturing |
|
Adeshwar Meditex Limited
Manufacturer and exporter of medical disposables, surgical …
|
543309 | IN | Manufacturing |
|
ADIAL PHARMACEUTICALS, INC.
A clinical-stage biopharma developing genetically targeted …
|
ADIL | US | Manufacturing |
|
Adicet Bio, Inc.
Develops allogeneic gamma delta T cell therapies for cancer…
|
ACET | US | Manufacturing |
|
ADIM
Develops and manufactures human vaccines and biologics for …
|
4142 | TW | Manufacturing |
Immix Biopharma, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/34423/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=34423 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=34423 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=34423 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 34423}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Immix Biopharma, Inc. (id: 34423)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.